|
|
|
| LEXIVA is indicated in combination with other antiretroviral agents for the treatment of HIV infection. |
| |
For PI-experienced patients, the following points should be considered: |
| • |
The protease inhibitor-experienced patient study was not large enough to reach a definitive conclusion that LEXIVA/ritonavir and lopinavir/ritonavir are clinically equivalent |
| • |
Once-daily administration of LEXIVA plus ritonavir is not recommended for protease inhibitor-experienced patients |
|
|
|
|
|
